<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04046757</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL17_0378</org_study_id>
    <nct_id>NCT04046757</nct_id>
  </id_info>
  <brief_title>Regional Strategy for Transfer for Mechanical Thrombectomy</brief_title>
  <acronym>START</acronym>
  <official_title>Strategy for Transfer to Emergency Head And Neck (UTEC) of Stroke Alerts With Suspicion of Large Vessel Occlusion for Mechanical Thrombectomy in the Languedoc Roussillon Region</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A mono-centre observational study with the aim of compare clinical outcome at 3 month on&#xD;
      patients admitted with recent cerebral infarct and intracranial large vessel occlusion in the&#xD;
      anterior circulation who are eligible for mechanical thrombectomy in three different position&#xD;
      : Patients admitted first in the Comprehensive Stroke Center of Montpellier, those&#xD;
      transferred after Proximity Stroke Unit or prehospital bypass for patients with high&#xD;
      suspicion of large vessel occlusion.to the Comprehensive Stroke Center of Montpellier&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multiple RCT has recently proved the superiority of mechanical thrombectomy compared to the&#xD;
      best medical therapy (BMT) on patients with recent cerebral infarct and anterior circulation&#xD;
      intracranial large vessel occlusion.&#xD;
&#xD;
      In the Occitanie-Est region (ex Languedoc Roussillon), comprising 6 Stroke Unit, only the&#xD;
      Comprehensive Stroke Unit of the CHU de Montpellier has a centre of interventional&#xD;
      neuroradiology (NRI) that can perform mechanical thrombectomy.&#xD;
&#xD;
      Patients suspected of stroke are referred to the nearest SU, then the candidates for&#xD;
      thrombectomy, are transferred secondarily to the Stroke Center in Montpellier.&#xD;
&#xD;
      Currently, there is no evidence that an initial management in a proximity stroke unit and a&#xD;
      secondary transfer for a mechanical thrombectomy is associated with a loss of chance for&#xD;
      patients, compared to patients initially treated at the Stroke Center regional reference.&#xD;
&#xD;
      The objective of the study is to compare clinical outcome on patients admitted first in the&#xD;
      Comprehensive Stroke Center of Montpellier those transferred after Proximity Stroke Unit or&#xD;
      directly admitted when high suspicion of large vessel occlusion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Rankin Score (mRS)</measure>
    <time_frame>3 months</time_frame>
    <description>Good functional outcome ( defined by a Modified Rankin Scale of 0-2, 3 months after stroke onset Modified Rankin scale . Range 0 (asymptomatic) to 6 (death)&#xD;
Good outcome : 0 to 2&#xD;
Disability : 3 to 5&#xD;
Bad outcome : 5 and 6</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of mechanical thrombectomy treatment</measure>
    <time_frame>24 hours</time_frame>
    <description>Safety of medical complication&#xD;
Complications of mechanical thrombectomy :&#xD;
Vessel perforation&#xD;
Intramural Arterial dissection&#xD;
Symptomatic Intracerebral hemorrhage&#xD;
embolization to a new territory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical evolution at 24 hours</measure>
    <time_frame>24 hours</time_frame>
    <description>NIHSS scale and NIHSS scale variation between the inclusion at 24 hours&#xD;
National Institutes of Health Stroke Scale (NIHSS). Range 0-42. Neurological severity score at the acute phase :&#xD;
Minor stroke : 0 to 5&#xD;
Moderate stroke 6 to 20&#xD;
Severe stroke up to 21</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical evolution 7 days</measure>
    <time_frame>7 days</time_frame>
    <description>NIHSS scale and NIHSS scale variation between the inclusion at 7 days&#xD;
National Institutes of Health Stroke Scale (NIHSS). Range 0-42. Neurological severity score at the acute phase :&#xD;
Minor stroke : 0 to 5&#xD;
Moderate stroke 6 to 20&#xD;
Severe stroke up to 21</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients having had mechanical trombectomy (and/or intravenous thrombolysis) amongst patient cohort.</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of patients having had mechanical trombectomy (and/or intravenous thrombolysis) amongst patient cohort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic Intracerebral Haemorrhage</measure>
    <time_frame>24 hours</time_frame>
    <description>symptomatic Intracerebral Haemorrhage on cerebral imaging at 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial Recanalisation with TICI score</measure>
    <time_frame>post-act / 24 hours</time_frame>
    <description>Quality of revascularization after mechanical thrombectomy : immediate post-Mechanical-Trombectomy evaluation for patient having had mechanical thrombectomy and at 24 hours for all patient cohort.&#xD;
TICI score (Thrombolysis In Cerebral Infarction grading system) describe the quality of revascularization after mechanical thrombectomy (Grade 0 for no perfusion at 3 for Complete perfusion)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Stroke</condition>
  <condition>Ischemic</condition>
  <condition>Large Vessel Occlusion</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mechanical thrombectomy</intervention_name>
    <description>Neuroradiological endovascular treatment</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Acute cerebral infarct in the arterial circulation with large vessel occlusion&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient, admitted to the Emergency Department Head and Neck of the CHU de Montpellier,&#xD;
             over 18 years old, without limit of upper age&#xD;
&#xD;
          2. With TIA or cerebral infarction (confirmed by brain imaging (MRI or CT scan), acute&#xD;
             (Time of stroke symptoms or discovery of patient â‰¤ 12 h)&#xD;
&#xD;
          3. With anterior circulation intracranial large vessel occlusion (M1, T or proximal M2),&#xD;
             confirmed by arterial imaging (magnetic resonance angiography-MRA- or angioscanner)&#xD;
&#xD;
          4. No objection of the patient or their representative to being included in the cohort&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient with severe intercurrent pathology impacting the short-term vital prognosis&#xD;
             and making follow-up impossible&#xD;
&#xD;
          2. Predictable impossibility of patient follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caroline ARQUIZAN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Caroline ARQUIZAN, MD</last_name>
    <phone>4 67 33 72 33</phone>
    <email>c-arquizan@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica HATTINGUAIS, CRA</last_name>
    <phone>4 67 33 56 53</phone>
    <phone_ext>+33</phone_ext>
    <email>j-hattinguais@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gui De Chauliac Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline ARQUIZAN, MD</last_name>
      <phone>c-arquizan@chu-montpellier.fr</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>June 7, 2019</study_first_submitted>
  <study_first_submitted_qc>August 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2019</study_first_posted>
  <last_update_submitted>October 25, 2019</last_update_submitted>
  <last_update_submitted_qc>October 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ischemic stroke</keyword>
  <keyword>Mechanical Thrombectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

